E6AP promotes the degradation of the PML tumor suppressor
I Louria-Hayon, O Alsheich-Bartok, Y Levav-Cohen, I Silberman, M Berger, T Grossman, K Matentzoglu, Y-H Jiang, S Muller, M Scheffner, S Haupt, Y Haupt
Cell Death & Differentiation | NATURE PUBLISHING GROUP | Published : 2009
Awarded by Israel Science Foundation
Awarded by Australian National Health and Medical Research Counci
Awarded by European Commission
We thank Z Nawaz, A Ben-Zeev, D Trono, L Banks and PP Pandolfi for their generous gifts of expression plasmids; A Beaudet for the E6AP KO mice; and PP Pandolfi for the PML KO MEFs. This work was supported by grants from the Association for International Cancer Research, the German-Israeli Foundation for Scientific Research and Development, the Israel Science Foundation (grant no. 1341/05), the Australian National Health and Medical Research Council to YH (no. 509196), and by the Active p53 project within the 6th framework program of the European Commission (contract 503576). The content of this publication reflects the author's views. European Commission is not liable for any that may be made of this information.